Applied Pathways Names New CEO

By | News

Applied Pathways LLC today announced that healthcare industry veteran Steve Lefar has assumed the role of Chief Executive Officer and will join its Board of Directors.  Founder and current CEO John Feldman will continue in an operating role as Chairman of the Board.


Key Points of Michael Dowling Talk at HEP Annual Meeting

By | News

Michael DowlingMichael J. Dowling is President and Chief Executive Officer of Northwell Health (formerly the North Shore-LIJ Health System). With 21 hospitals, more than 450 outpatient physician practices and a full complement of long-term care services, Northwell Health is one of the nation’s largest health systems, with nearly $8 billion in annual revenue. Michael served in New York State government for 12 years, including seven years as state director of Health, Education and Human Services and deputy secretary to the governor. He was also commissioner of the New York State Department of Social Services. Earlier this month, Mr. Dowling spoke to the audience of the HEP Annual Meeting about issues affecting large hospital systems, the healthcare industry in general, and the Hofstra Northwell School of Medicine. Read More

SCIO Health Analytics Announces Strategic Relationship With Lockton Benefit Group

By | News

Lockton Benefit Group today announced a material investment in its InfoLock® data intelligence platform. The enhancements to the platform improve Lockton’s ability to partner with their clients to identify health trends and respond to areas driving the cost of health. Lockton uses InfoLock to advise employers on developing comprehensive health management programs to address the continuum of health risks across their working population. Read more.

SV Life Sciences and Health Enterprise Partners Announce Formation of Jet Health

By | News

Accomplished healthcare executive Jim Glynn to lead home healthcare platform

For Immediate Release

Irvine, CA, April 15, 2016 – SV Life Sciences Advisers (“SVLS”) and Health Enterprise Partners (“HEP”) announced today that they have partnered with experienced healthcare services executive Jim Glynn to form Jet Health, Inc. (“Jet Health”). The new company will develop, acquire, and operate home health care companies as part of a strategy to build a leading national home health platform. SVLS, HEP and Mr. Glynn have committed significant equity capital to fund the growth of Jet Health.

Jim Glynn, Jet Health’s CEO, is a seasoned and highly accomplished home health care executive with deep expertise in building, acquiring, and growing home health care and home infusion businesses. Previously, Mr. Glynn served as CEO of Amerita, Inc., a private equity-backed specialty infusion platform. Mr. Glynn founded Amerita in 2006 and successfully grew the company to become the fifth largest specialty infusion provider in the U.S., with 18 locations generating $140 million in annualized revenue. Prior to his tenure at Amerita, Jim served in various senior management roles at Apria Healthcare, Gentiva Health Services, and Coram Healthcare.  “At Amerita, Jim successfully built a health care services company that empowered local operators and clinicians to deliver high quality services in growing markets. We are excited to partner with Jim to replicate that model in home health care,” said Tom Flynn, Managing Partner at SVLS.

Home health care is a diversified industry comprised of skilled nursing care, physical, speech and occupational therapy, rehabilitative care, medical social services, personal care, and companion services. Jim stated, “The home health industry is poised to continue its strong recent growth driven by an aging U.S. population, patient preference to be treated in a comfortable and convenient setting at home, and significant cost savings relative to care in inpatient or nursing home facilities. I look forward to building Jet Health into a premier home health business in partnership with SVLS and HEP.” California-based Jet Health plans to leverage local brands and operating expertise while sharing best practices across its companies and centralizing traditional back office functions.  Dave Tamburri, Partner at HEP, commenting on the critical role home health care plays in the post-acute care continuum, “Under Jim’s proven leadership, Jet Health will seek to partner with health systems and other providers to bring innovative approaches to post-acute care.”

About SV Life Sciences Advisers
SV Life Sciences Advisers, LLC (“SVLS”) is a global leader in healthcare and life sciences investing. SVLS affiliated funds have been investing in such companies since the early 1980s, forming its first dedicated healthcare fund in 1994. Today, SVLS manages five funds with approximately $2.0 billion of capital commitments under management. The firm has invested in over 175 companies through its venture funds, and employs a diversified investment strategy capitalizing on opportunities in the following subsectors; therapeutics, medical devices, healthcare information technology (HCIT) and healthcare services. SVLS employs a close symbiosis between operating and financial professionals which has led to significant success over five investment funds. SVLS has offices in Boston, London and San Francisco. For more information, please visit the company’s website at

About Health Enterprise Partners
Health Enterprise Partners invests primarily in privately held, profitable, middle market companies in the health care information technology and health care service sectors. HEP’s strategy is to leverage its unique and extensive hospital system and health plan network, 26 members of which are investors in HEP’s funds. HEP seeks to invest in companies that improve the quality of the patient experience, reduce the cost of health care, and improve operating margins for their customers, typically hospital systems and / or health plans. For more information, please visit

Download pdf